E-cadherin and beta-catenin expression in Epstein-Barr virus-associated gastric carcinoma and their prognostic significance

Table 1 Membranous and cytoplasmic expression of E-cadherin in EBV-GCs and non EBV-GCs

Location of E-cadherin expression	Number of the cases (%)		OR1	95% CI1
	EBV-GCs	non EBV-GCs
Total	59	120
Membranous
Preserved (> 50%)	14 (24)	29 (24)	1	Referent
Lost (< 50%)	45 (76)	91 (76)	0.99	0.48-2.05
Cytoplasm
Negative	26 (44)	59 (49)	1	Referent
Positive (subtotal)	33 (56)	61 (51)	1.28	0.65-2.50
10%-	17 (29)	29 (24)	1.37	0.62-3.01
50%-	11 (19)	29 (24)	0.92	0.39-2.18
90%-	5 (8)	3 (3)	3.98	0.88-18.0
			P = 0.374

¹ORs and 95% CIs were obtained from conditional logistic regression analysis with the objective variable being EBV-GC (EBV-GC = 1, and non EBV-GC = 0).